Johanna Willemina Pattenier
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Johanna Willemina Pattenier
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
16
| Public Company | Biotechnology | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Johanna Willemina Pattenier
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
SEQUANS COMMUNICATIONS S.A. | Semiconductors | Director/Board Member | |
Groupe Limagrain Holding SA
Groupe Limagrain Holding SA Agricultural Commodities/MillingProcess Industries Groupe Limagrain Holding SA engages in agricultural production. It offers wheat, corn, maize, sunflower, rapeseed, tomato, carrot, melon, cauliflower, and pepper, as well as flower seeds. The company was founded in 1965 and is headquartered in Saint-Beauzire, France. | Agricultural Commodities/Milling | Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
Groupe Grimaud La Corbière SA
Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Chief Executive Officer Director/Board Member | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
University of Technology Sydney | College/University | Undergraduate Degree | |
University of Gottingen | College/University | Doctorate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Institut d'Études Politiques d'Aix-en-Provence | College/University | Undergraduate Degree | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst | |
Novasep Holding SAS
Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
eZono AG
eZono AG Medical SpecialtiesHealth Technology eZono AG develops portable ultrasound system. Its product eZono 3000 is a portable ultrasound system designed for the needs of anaesthetists. The company was founded by Allan R. Dunbar and Andre Jaekel in July 2004 and is headquartered in Jena, Germany. | Medical Specialties | Director/Board Member | |
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MVM Executive Ltd. | Director/Board Member | ||
MVM (CIP) (No.3) Ltd. | Director/Board Member | ||
MVM (CIP) (No.2) Ltd. | Director/Board Member | ||
MVM (GP) Ltd. | Director/Board Member | ||
MVM (GP) (No. 2) Ltd. | Director/Board Member | ||
Fonds Stratégique d'Investissement Fund
Fonds Stratégique d'Investissement Fund Investment ManagersFinance Fonds Stratégique d'Investissement was created by the French Government in 2008 and integrated BPIFrance on 2013. This fund invests in small and middle sized French companies. | Investment Managers | Chief Investment Officer | |
Dassiet Oy
Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor | |
MVM Gp (No.3) Scottish LP | Director/Board Member | ||
Devialet SA
Devialet SA Electronics/AppliancesConsumer Durables Devialet SA manufactures audio integrated amplifiers. Its products include Devialet 120, Devialet 400, Devialet 200, and Devialet 800. The firm also offers home audio amplification system called Devialet ensemble, D-Premier, and Devialet 250. The company was founded by Pierre-Emmanuel Calmel, Mathias Moronvalle, Emmanuel Nardin, and Quentin Sannié in 2007 and is headquartered in Paris, France. | Electronics/Appliances | Director/Board Member | |
PIXIUM VISION | Medical Specialties | Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Bpifrance Participations SA | Financial Conglomerates | Chief Investment Officer | |
Doctolib SAS
Doctolib SAS Packaged SoftwareTechnology Services Doctolib SAS develops software for the health industry. This software improves the efficiency of hospitals and reinforces the cooperation with colleagues. The company was founded by Ivan Schneider, Jessy Bernal, and Stanislas Niox-Chateau on August 5, 2013 and is headquartered in Levallois-Perret, France. | Packaged Software | Director/Board Member | |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cornovum SASU
Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer | |
Executive Perspective Consulting LLC
Executive Perspective Consulting LLC Miscellaneous Commercial ServicesCommercial Services Executive Perspective Consulting LLC provides business consulting services. The private company is based in River Edge. | Miscellaneous Commercial Services | President | |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member | |
Valneva UK Ltd.
Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member | |
Dynavax GmbH
Dynavax GmbH Pharmaceuticals: MajorHealth Technology Part of Dynavax Technologies Corp., Dynavax GmbH is a pharmaceutical company based in Dusseldorf, Germany. The German company manufactures pharmaceutical products. The CEO of the company is Hans Eric Frings. | Pharmaceuticals: Major | Chief Executive Officer | |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Operating Officer | |
MVM Scotland (No. 3) GP Ltd. | Director/Board Member | ||
Patient Connect Ltd.
Patient Connect Ltd. Medical/Nursing ServicesHealth Services Patient Connect Ltd. provides supporting services for patients at the point of dispensing. It operates a community where pharmacists provide medicines to help patients. The firm offers patient compliance services. The company was founded by Grace Lomax and Zoe Barker in 2004 and is headquartered in Guildford, the United Kingdom. | Medical/Nursing Services | Chairman |
Statistik
International
Frankreich | 21 |
Vereinigtes Königreich | 15 |
Vereinigte Staaten | 7 |
Niederlande | 4 |
Deutschland | 4 |
Sektoral
Health Technology | 21 |
Finance | 9 |
Consumer Services | 5 |
Commercial Services | 4 |
Process Industries | 3 |
Operativ
Director/Board Member | 65 |
Corporate Officer/Principal | 31 |
Chairman | 28 |
President | 17 |
Director of Finance/CFO | 14 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Frédéric Grimaud | 33 |
Sharon Tetlow | 21 |
Maïlys Ferrère | 21 |
Thomas Casdagli | 18 |
Peter Buhler | 14 |
Jim Connolly | 12 |
Alexander Ullrich von Gabain | 11 |
Sandra E. Poole | 10 |
Kathrin Jansen | 7 |
Louisa Shaw-Marotto | 5 |
Juan Carlos Jaramillo | 5 |
Klaus Schwamborn | 4 |
Wolfgang Bender | 4 |
Dipal Patel | 4 |
Perry Denis Celentano | 2 |
- Börse
- Insiders
- Johanna Willemina Pattenier
- Unternehmensverbindungen